OnCo
termsTerm

Brain metastases (intracranial disease)

aka brain metastasis, intracranial, intracranial metastases, CNS metastases, CNS disease, CNS activity, intracranial response, intracranial ORR, CNS relapse, brain mets

Tumour deposits that have travelled to the brain from a cancer elsewhere; ten times more common than cancers that start in the brain. Whether a drug can reach and shrink them is now a key property of new cancer medicines.

Lung cancer, breast cancer (especially HER2-positive and triple-negative), melanoma and kidney cancer account for most cases; 30-50% of driver-positive lung cancer patients develop them. Local treatment is stereotactic radiosurgery or surgery for limited disease and whole-brain radiotherapy for extensive disease. Because the blood-brain barrier excludes many drugs, CNS penetration and intracranial response rates (osimertinib, lorlatinib, tucatinib, T-DXd in DESTINY-Breast12) increasingly determine which drug is chosen, and trials now report intracranial progression-free survival separately.

Category
Anatomy

Connected

10top